Showing results 1 to 3 of 3
| Title | Author(s) | Issue Date | |
|---|---|---|---|
| 2021 | |||
Early on-treatment hbv rna and HBcrAg profiles predict favourable HBsAg suppression or seroclearance upon long-term nucleos(t)ide analogue therapy in chronic hepatitis B infection Proceeding/Conference:Poster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology | 2021 | ||
HBV pgRNA and HBcrAg reductions at week 4 predict favourable HBsAg response upon long-term nucleos(t)ide analogue in CHB Journal:Clinical and Molecular Hepatology | 2022 |